|
A pharmacy that dispenses controlled dangerous substances (CDS) within New Jersey is required to obtain a New Jersey CDS registration. If appropriate, please complete the initial “Dispenser – Pharmacy” application found at
https://www.njconsumeraffairs.gov/dcu/Pages/applications.aspx. Please note, when applying for a CDS registration an out-of-state pharmacy must use the same address of record filed with the New Jersey Board of Pharmacy. If you submit your application by email, an invoice which will include instructions for submitting payment, will be sent to your recorded email address. Please review the application instruction sheet for additional information and instructions. For additional questions regarding a CDS pharmacy registration, please email
CDS@dca.njoag.gov. |
Mid-level Practitioner CDS Registration Renewal
As detailed in Executive Order #112 and DCA-AO-2020-02, the requirements for an APN to enter into a joint protocol with a collaborating physician and a PA to enter into a signed delegation agreement, are suspended for the duration of the state of emergency declared in response to the COVID-19 pandemic. Renewal of a midlevel CDS registration during the state of emergency is permissible and questions regarding the existence of a joint protocol or delegation agreement should be answered truthfully. Following the state of emergency, midlevel practitioners must enter into a joint protocol or delegation agreement to continue to prescribe and/or administer controlled dangerous substances. |
|
Out-of-State Pharmacy CDS Registration
Out-of-state pharmacies that dispense controlled dangerous substances within New Jersey are required to obtain a CDS registration. The application will be available on the “Applications and Forms” section of this page in the near future, at which time you must apply. To be placed on an email list to receive updates on this matter, please email
CDS@dca.lps.state.nj.us. Please continue to check this webpage for updates and complete your pharmacy renewal as instructed.
(05/06/19) |
|
Optometrist CDS Registration Update
The Optometrist Controlled Dangerous Substances (CDS) Registration has been updated to read “SCH II CDS NOT VALID, EXCEPT FOR HYDROCODONE PRODUCTS”, in accordance with N.J.A.C. 13:38-2.4(h). Optometrists who maintain an active CDS registration will receive an updated registration within the next month. Once the new CDS registration is received, registrants should destroy the old CDS registration.
Please send any questions you may have to
CDS@dca.lps.state.nj.us.
(8/18/19) |
|
CDS Registration Fee Increase
On February 19, 2019, the Drug Control Unit increased the Controlled Dangerous Substance (CDS) registration fees. Note that the CDS registration fees in effect up through February 18, 2019 will be accepted through March 19, 2019.
View More (02/28/19) |
|
Nelson Press Terminated as an Approved Pinter Vendor
As of July 13, 2018, Nelson Press has been terminated as an approved printer vendor of the New Jersey Prescription Blanks Program.
View More (7/13/18) |
|
Revision of Healthcare Facility New Jersey Prescription Blanks
Due to changes to the laws governing the prescription authority for Optometrists and Physician Assistants, the New Jersey Prescription Blanks Program revised the Healthcare Facility (HCF) New Jersey Prescription Blank (NJPB). Through March 31, 2017, practitioners may write valid prescriptions on either the old or the new healthcare facility prescription blanks. Starting April 1, 2017, practitioners must use the new healthcare facility blank to issue prescriptions for their patients.
View More (10/14/15) |
|
Data Business Systems Suspended as an Approved Printer Vendor
As of September 24, 2015, Data Business Systems, Inc. has been suspended for a period of three (3) months, as an approved printer vendor of the New Jersey Prescription Blanks Program.
View More (10/06/15) |
|
Electronic Prescribing of Controlled Substances (EPCS) for a Pharmacy
On January 7, 2013 the Board of Pharmacy and Drug Control Unit adopted rules to allow pharmacies to receive Schedule II controlled substances prescriptions electronically in accordance with federal requirements. New Jersey practitioners and pharmacies can utilize EPCS for all patient prescriptions.
View More (10/05/15) |
|
Electronic Prescribing of Controlled Substances (EPCS) for a Practitioner
On January 7, 2013 the Board of Pharmacy and Drug Control Unit adopted rules to allow prescribers to issue Schedule II controlled substances prescriptions electronically in accordance with federal requirements. New Jersey practitioners and pharmacies can utilize EPCS for all patient prescriptions.
View More (10/05/15) |
|
Physician Issuance of Multiple Prescriptions for Schedule II Controlled Substances
The New Jersey Division of Consumer Affairs is re-issuing the following guidance regarding the issuance of multiple prescriptions of a Schedule II controlled dangerous substance by a physician to a patient
View More(10/05/15) |
|
Information About the New NJ PMP Law.
In July, Senate Bill 1998 was signed into law (P.L.2015, c.74) which substantially revises the scope and expands the capabilities of the New Jersey Prescription Monitoring Program (NJPMP). The Division of Consumer Affairs is tasked with implementing the new law, which takes effect on November 1, 2015.
View More
(9/25/15) |
|
Nelson Press Terminated as an Approved Printer Vendor
As of April 1, 2015, Nelson Press has been terminated as an approved printer vendor of the New Jersey Prescription Blanks Program.
View More (04/01/15) |
|
Information to Pharmacists Regarding Schedule II Controlled Dangerous Substance Dispensing Limits for Liquids
The Division of Consumer Affairs, in conjunction with the Board of Pharmacy, is providing the following information to pharmacists concerning the dispensing limits of Schedule II Controlled Dangerous Substances (CDS) for liquid medications.
View More (03/31/15) |
|
Notification of the Rescheduling of Hydrocodone
Effective October 6, 2014, all Hydrocodone Combination Products are rescheduled as a Schedule II Controlled Dangerous Substance (CDS) in the State of New Jersey based on the recent federal Drug Enforcement Agency ("DEA") Final Rule. Please read the following information which outlines the limitations of a Schedule II CDS medication prescription.
View More (09/25/14) |
|
Optometrist OM-TPA Guidance for Pharmacies
The Division of Consumer Affairs, in conjunction with the Board of Pharmacy, is providing the following information concerning Doctors of Optometry (O.D.), Optometrists, and the medication prescriptive authority granted to Optometrists with a Therapeutic Pharmaceutical Agent (TPA) Certification, in order to assist pharmacists and pharmacy personnel in filling prescription issued by Optometrists.
View More (09/25/14) |
|
Notification of the Scheduling of Tramadol
Effective August 18, 2014, Tramadol is a Schedule IV Controlled Dangerous Substance in the State of New Jersey based on the recent federal Drug Enforcement Agency ("DEA") Final Rule placing Tramadol in Schedule IV.
View More (09/19/14) |
